ADAMTS-13-regulated nuclear factor E2-related factor 2 signaling inhibits ferroptosis to ameliorate cisplatin-induced acute kidney injuy
Author:
Affiliation:
1. Department of Nephrology, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China
2. Department of General Surgery, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China
Funder
funding associated with the work featured in this article
Publisher
Informa UK Limited
Subject
Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology
Link
https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.1994707
Reference34 articles.
1. AKI!Now Initiative: Recommendations for Awareness, Recognition, and Management of AKI
2. Acute Kidney Injury
3. A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity
4. Stevia and stevioside protect against cisplatin nephrotoxicity through inhibition of ERK1/2, STAT3, and NF-κB activation
5. The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Visual analysis on ferroptosis and its cross-talk to coronavirus disease 2019 (COVID-19);Heliyon;2024-09
2. The significance of ferroptosis in renal diseases and its therapeutic potential;Heliyon;2024-08
3. The role of ferroptosis in acute kidney injury: mechanisms and potential therapeutic targets;Molecular and Cellular Biochemistry;2024-06-28
4. Ferroptosis: A new mechanism of traditional Chinese medicine compounds for treating acute kidney injury;Biomedicine & Pharmacotherapy;2023-07
5. Bibliometric analysis of ferroptosis in acute kidney injury from 2014 to 2022;International Urology and Nephrology;2023-01-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3